Related Experiment Video
Updated: Aug 7, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Imaging correlates of posterior cortical atrophy
Jennifer L Whitwell1, Clifford R Jack, Kejal Kantarci
1Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Neurobiology of Aging
|June 27, 2006
Summary
Posterior cortical atrophy (PCA) shows distinct brain atrophy patterns compared to typical Alzheimer's disease (AD). Neuroimaging reveals unique MRI findings, supporting PCA as a separate neurological entity.
Area of Science:
- Neuroimaging
- Neurology
- Biochemistry
Background:
- Posterior cortical atrophy (PCA) and typical Alzheimer's disease (AD) are neurodegenerative conditions.
- Distinguishing between PCA and AD is crucial for accurate diagnosis and treatment.
- Both conditions involve brain atrophy, but the patterns may differ.
Purpose of the Study:
- To compare cerebral atrophy patterns using MRI and neurochemistry using magnetic resonance spectroscopy (MRS).
- To differentiate between patients with PCA and typical AD.
- To investigate PCA as a distinct clinical entity.
Main Methods:
- Voxel-based morphometry (VBM) for grey matter atrophy assessment.
- Magnetic resonance spectroscopy (MRS) for neurochemical analysis in the posterior cingulate.
- Comparison of 38 PCA patients, 38 AD patients, and 38 controls.
Main Results:
- PCA exhibited atrophy in occipital, parietal, and posterior temporal lobes, more severe on the right.
- PCA patients showed greater right visual association cortex atrophy than AD patients.
- AD patients displayed greater left hippocampal atrophy than PCA patients.
- (1)H MRS indicated neuronal loss and glial activation in both PCA and AD.
Conclusions:
- Distinct patterns of cerebral atrophy on MRI support PCA as a separate entity from typical AD.
- Neuroimaging and neurochemical findings highlight key differences in brain involvement.
- Further research is warranted to fully elucidate the distinct pathologies of PCA and AD.
